Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Brookfield CorporationCL A(BN) | 2,330,830 | 3,496,245 | +1,165,415 | $159.85M | $160.44M | 12.46% | +$594.4K |
| Edgewise Therapeutics, Inc.(EWTX) | 5,350,000 | 5,350,000 | 0 | $86.78M | $132.76M | 10.31% | +$45.98M |
| Asml Holding N VN Y REGISTRY SHS N Y REGISTRY SHS | 145,836 | 113,946 | -31,890 | $141.18M | $121.91M | 9.47% | -$19.28M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 1,264,028 | 1,264,028 | 0 | $92.67M | $99.85M | 7.75% | +$7.18M |
| Salesforce, Inc.(CRM) | 330,187 | 330,187 | 0 | $78.25M | $87.47M | 6.79% | +$9.22M |
| Crinetics Pharmaceuticals In | 1,625,000 | 1,625,000 | 0 | $67.68M | $75.64M | 5.87% | +$7.96M |
| Viridian Therapeutics, Inc.(VRDN) | 2,380,000 | 2,380,000 | 0 | $51.36M | $74.07M | 5.75% | +$22.71M |
| MapLight Therapeutics, Inc.(MPLT) | 0 | 3,686,622 | +3,686,622 | $0 | $64.76M | 5.03% | +$64.76M |
| Zenas BioPharma, Inc.(ZBIO) | 2,000,000 | 1,450,000 | -550,000 | $44.40M | $52.65M | 4.09% | +$8.25M |
| Pharvaris N V COM | 1,750,000 | 1,750,000 | 0 | $43.66M | $48.56M | 3.77% | +$4.90M |
| Apogee Therapeutics Inc | 500,000 | 570,000 | +70,000 | $19.86M | $43.02M | 3.34% | +$23.16M |
| Vaxcyte, Inc.(PCVX) | 916,160 | 916,160 | 0 | $33.00M | $42.27M | 3.28% | +$9.27M |
| BioMarin Pharmaceutical Inc.(BMRN) | 660,000 | 660,000 | 0 | $35.75M | $39.22M | 3.05% | +$3.48M |
| ArriVent BioPharma, Inc.(AVBP) | 1,942,142 | 1,942,142 | 0 | $35.83M | $39.08M | 3.03% | +$3.24M |
| Alibaba Group Holding LimitedADS(BABA) | 257,327 | 257,327 | 0 | $45.99M | $37.72M | 2.93% | -$8.27M |
| Insmed Incorporated(INSM) | 200,000 | 200,000 | 0 | $28.80M | $34.81M | 2.70% | +$6.01M |
| Celldex Therapeutics, Inc.(CLDX) | 1,200,000 | 1,200,000 | 0 | $31.04M | $32.59M | 2.53% | +$1.55M |
| 4d Molecular Therapeutics In | 2,000,000 | 3,650,737 | +1,650,737 | $17.38M | $27.38M | 2.13% | +$10.00M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 1,961,317 | 1,961,317 | 0 | $22.71M | $24.56M | 1.91% | +$1.84M |
| Enliven Therapeutics Inc | 1,426,260 | 1,480,000 | +53,740 | $29.20M | $22.79M | 1.77% | -$6.40M |
| Valneva SEADS(VALN) | 2,345,000 | 2,305,000 | -40,000 | $28.61M | $20.33M | 1.58% | -$8.28M |
| LanzaTech Global, Inc.(LNZA) | 158,148 | 158,148 | 0 | $3.88M | $2.18M | 0.17% | -$1.70M |
| Marqeta, Inc.CL A(MQ) | 441,558 | 441,558 | 0 | $2.33M | $2.10M | 0.16% | -$234.0K |
| Io Biotech Inc | 2,512,453 | 2,512,453 | 0 | $912.3K | $1.53M | 0.12% | +$617.6K |
| Damora Therapeutics, Inc.(DMRA) | 86,579 | 0 | -86,579 | $322.1K | $0 | — | -$322.1K |
| Merus N V | 750,000 | 0 | -750,000 | $70.61M | $0 | — | -$70.61M |
| Recursion Pharmaceuticals, Inc.CL A(RXRX) | 7,929,835 | 0 | -7,929,835 | $38.70M | $0 | — | -$38.70M |
| Vanguard Index FdsTotal Stock Market | 1,038,550 | 0 | -1,038,550 | $340.82M | $0 | — | -$340.82M |